Abstract | BACKGROUND: OBJECTIVES: Here we report effects of tVNS on cardiac function from a pilot study, which was conducted to evaluate the feasibility and safety of tVNS for the treatment of chronic tinnitus. METHODS: Twenty-four patients with chronic tinnitus underwent treatment with tVNS over 3-10 weeks in an open single-armed pilot study. Safety criteria and practical usability of the neurostimulating device were to investigate by clinical examination and electrocardiography at baseline and at several visits during and after tVNS treatment (week 2, 4, 8, 16, and 24). RESULTS: Two adverse cardiac events (one classified as a severe adverse event) were registered but considered very unlikely to have been caused by the tVNS device. Retrospective analyses of electrocardiographic parameters revealed a trend toward shortening of the QRS complex after tVNS. CONCLUSION: To our knowledge this is one of the first studies investigating feasibility and safety of tVNS in a clinical sample. In those subjects with no known pre-existing cardiac pathology, preliminary data do not indicate arrhythmic effects of tVNS.
|
Authors | Peter M Kreuzer, Michael Landgrebe, Oliver Husser, Markus Resch, Martin Schecklmann, Florian Geisreiter, Timm B Poeppl, Sarah Julia Prasser, Goeran Hajak, Berthold Langguth |
Journal | Frontiers in psychiatry
(Front Psychiatry)
Vol. 3
Pg. 70
( 2012)
ISSN: 1664-0640 [Electronic] Switzerland |
PMID | 22891061
(Publication Type: Journal Article)
|